Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) EBT Margin (2016 - 2025)

Historic EBT Margin for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 8.5%.

  • Medifast's EBT Margin fell 95700.0% to 8.5% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.46%, marking a year-over-year decrease of 20900.0%. This contributed to the annual value of 1.46% for FY2025, which is 20900.0% down from last year.
  • Medifast's EBT Margin amounted to 8.5% in Q4 2025, which was down 95700.0% from 2.97% recorded in Q3 2025.
  • Over the past 5 years, Medifast's EBT Margin peaked at 15.56% during Q2 2021, and registered a low of 8.5% during Q4 2025.
  • For the 5-year period, Medifast's EBT Margin averaged around 7.08%, with its median value being 10.19% (2022).
  • In the last 5 years, Medifast's EBT Margin plummeted by -195300bps in 2024 and then skyrocketed by 90400bps in 2025.
  • Medifast's EBT Margin (Quarter) stood at 12.37% in 2021, then dropped by -22bps to 9.61% in 2022, then tumbled by -47bps to 5.13% in 2023, then plummeted by -79bps to 1.07% in 2024, then plummeted by -893bps to 8.5% in 2025.
  • Its EBT Margin stands at 8.5% for Q4 2025, versus 2.97% for Q3 2025 and 2.72% for Q2 2025.